These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 25799509)

  • 1. DNA methyltransferase inhibitor zebularine induces human cholangiocarcinoma cell death through alteration of DNA methylation status.
    Nakamura K; Nakabayashi K; Htet Aung K; Aizawa K; Hori N; Yamauchi J; Hata K; Tanoue A
    PLoS One; 2015; 10(3):e0120545. PubMed ID: 25799509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methyltransferase inhibitor zebularine inhibits human hepatic carcinoma cells proliferation and induces apoptosis.
    Nakamura K; Aizawa K; Nakabayashi K; Kato N; Yamauchi J; Hata K; Tanoue A
    PLoS One; 2013; 8(1):e54036. PubMed ID: 23320119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The DNA methyltransferase inhibitor zebularine induces mitochondria-mediated apoptosis in gastric cancer cells in vitro and in vivo.
    Tan W; Zhou W; Yu HG; Luo HS; Shen L
    Biochem Biophys Res Commun; 2013 Jan; 430(1):250-5. PubMed ID: 23167995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zebularine enhances apoptosis of human osteosarcoma cells by suppressing methylation of ARHI.
    Ye K; Wang S; Wang J; Han H; Ma B; Yang Y
    Cancer Sci; 2016 Dec; 107(12):1851-1857. PubMed ID: 27685841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zebularine inhibits human acute myeloid leukemia cell growth in vitro in association with p15INK4B demethylation and reexpression.
    Scott SA; Lakshimikuttysamma A; Sheridan DP; Sanche SE; Geyer CR; DeCoteau JF
    Exp Hematol; 2007 Feb; 35(2):263-73. PubMed ID: 17258075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The DNA methyltransferase inhibitors zebularine and decitabine induce mitochondria-mediated apoptosis and DNA damage in p53 mutant leukemic T cells.
    Ruiz-Magaña MJ; Rodríguez-Vargas JM; Morales JC; Saldivia MA; Schulze-Osthoff K; Ruiz-Ruiz C
    Int J Cancer; 2012 Mar; 130(5):1195-207. PubMed ID: 21455989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous zebularine treatment effectively sustains demethylation in human bladder cancer cells.
    Cheng JC; Weisenberger DJ; Gonzales FA; Liang G; Xu GL; Hu YG; Marquez VE; Jones PA
    Mol Cell Biol; 2004 Feb; 24(3):1270-8. PubMed ID: 14729971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zebularine induces prolonged apoptosis effects via the caspase-3/PARP pathway in head and neck cancer cells.
    Napso T; Fares F
    Int J Oncol; 2014 Jun; 44(6):1971-9. PubMed ID: 24728469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zebularine suppresses the apoptotic potential of 5-fluorouracil via cAMP/PKA/CREB pathway against human oral squamous cell carcinoma cells.
    Suzuki M; Shinohara F; Endo M; Sugazaki M; Echigo S; Rikiishi H
    Cancer Chemother Pharmacol; 2009 Jul; 64(2):223-32. PubMed ID: 18830594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a novel DNA methyltransferase inhibitor zebularine on human breast cancer cells.
    Billam M; Sobolewski MD; Davidson NE
    Breast Cancer Res Treat; 2010 Apr; 120(3):581-92. PubMed ID: 19459041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of in vitro and in vivo tumor cell radiosensitivity by the DNA methylation inhibitor zebularine.
    Dote H; Cerna D; Burgan WE; Carter DJ; Cerra MA; Hollingshead MG; Camphausen K; Tofilon PJ
    Clin Cancer Res; 2005 Jun; 11(12):4571-9. PubMed ID: 15958643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced growth inhibition by combined DNA methylation/HDAC inhibitors in lung tumor cells with silenced CDKN2A.
    Chen M; Voeller D; Marquez VE; Kaye FJ; Steeg PS; Giaccone G; Zajac-Kaye M
    Int J Oncol; 2010 Oct; 37(4):963-71. PubMed ID: 20811718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimitogenic and chemosensitizing effects of the methylation inhibitor zebularine in ovarian cancer.
    Balch C; Yan P; Craft T; Young S; Skalnik DG; Huang TH; Nephew KP
    Mol Cancer Ther; 2005 Oct; 4(10):1505-14. PubMed ID: 16227399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
    Shin H; Kim JH; Lee YS; Lee YC
    Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zebularine: a unique molecule for an epigenetically based strategy in cancer chemotherapy.
    Marquez VE; Kelley JA; Agbaria R; Ben-Kasus T; Cheng JC; Yoo CB; Jones PA
    Ann N Y Acad Sci; 2005 Nov; 1058():246-54. PubMed ID: 16394141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of DNA methylation and reactivation of silenced genes by zebularine.
    Cheng JC; Matsen CB; Gonzales FA; Ye W; Greer S; Marquez VE; Jones PA; Selker EU
    J Natl Cancer Inst; 2003 Mar; 95(5):399-409. PubMed ID: 12618505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines.
    Fang MZ; Wang Y; Ai N; Hou Z; Sun Y; Lu H; Welsh W; Yang CS
    Cancer Res; 2003 Nov; 63(22):7563-70. PubMed ID: 14633667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA methyltransferase 1 knockdown induces silenced CDH1 gene reexpression by demethylation of methylated CpG in hepatocellular carcinoma cell line SMMC-7721.
    Fan H; Zhao Z; Quan Y; Xu J; Zhang J; Xie W
    Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):952-61. PubMed ID: 18049164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic Silencing of miRNA-34a in Human Cholangiocarcinoma via EZH2 and DNA Methylation: Impact on Regulation of Notch Pathway.
    Kwon H; Song K; Han C; Zhang J; Lu L; Chen W; Wu T
    Am J Pathol; 2017 Oct; 187(10):2288-2299. PubMed ID: 28923203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells.
    Robert MF; Morin S; Beaulieu N; Gauthier F; Chute IC; Barsalou A; MacLeod AR
    Nat Genet; 2003 Jan; 33(1):61-5. PubMed ID: 12496760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.